Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Bioxcel Therapeutics Inc
(NQ:
BTAI
)
2.570
+0.010 (+0.39%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Bioxcel Therapeutics Inc
< Previous
1
2
3
4
5
6
7
8
Next >
ChatGPT Is Just The 'Tip Of The Iceberg' In Content-Creating Artificial Intelligence; Get Ready For 'A Lot Of Disruption' (Not Just At Google)
February 03, 2023
"A lot of disruption" may be coming soon to a host of industries. Google may be at risk.
Via
Investor's Business Daily
CRISPR, Genetics And AI — Why 2023 Could Be The Year For Biotech Stocks
January 06, 2023
Genetic medicine is a top theme now for biotech stocks. Other trends are heating up too.
Via
Investor's Business Daily
Why BioXCel Therapeutics Stock Jumped This Week
December 15, 2022
A couple of analysts recently upgraded their views on the biotech stock.
Via
The Motley Fool
2 Beaten-Down Stocks to Watch Closely Next Year
December 06, 2022
These biotechs could skyrocket in 2023, but only if they can execute their plans.
Via
The Motley Fool
Analyst Ratings for BioXcel Therapeutics
December 01, 2022
Via
Benzinga
Is This Soaring Growth Stock a Buy?
November 20, 2022
The answer may depend on your risk tolerance.
Via
The Motley Fool
Recap: BioXcel Therapeutics Q2 Earnings
August 09, 2022
BioXcel Therapeutics (NASDAQ:BTAI) reported its Q2 earnings results on Tuesday, August 9, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
BioXcel Therapeutics: Q1 Earnings Insights
May 09, 2022
BioXcel Therapeutics (NASDAQ:BTAI) reported its Q1 earnings results on Monday, May 9, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Why BioXcel Therapeutics Stock Triumphed This Week
December 02, 2022
An analyst feels that the best is shortly to come for the company.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For December 1, 2022
December 01, 2022
Via
Benzinga
Cramer On This Stock Down 65% Year-To-Date: 'I Do Believe It's Bottoming, But I Don't Know What Gets It Higher'
November 18, 2022
On CNBC’s "Mad Money Lightning Round," Jim Cramer said BioXcel Therapeutics Inc (NASDAQ: BTAI) "may be home run or nothing, and that’s always tough."
Via
Benzinga
Oaktree, Qatar Investment Inject $260M In BioXcel To Fund Commercialization Of Schizophrenia Med
April 19, 2022
Via
Benzinga
Why Apyx Medical Shares Dipped Over 60%; Here Are 123 Biggest Movers From Yesterday
November 11, 2022
Gainers
Via
Benzinga
Twitter Shares Surge Around 8%, Here's 66 Biggest Movers From Yesterday
July 14, 2022
Gainers Qurate Retail, Inc. (NASDAQ: QRTEB) shares climbed 71.1% to close at $5.20. Qurate Retail will host a conference call to discuss Q2 results on Friday, August 5th.
Via
Benzinga
24 Stocks Moving in Thursday's Pre-Market Session
June 02, 2022
Gainers Immix Biopharma, Inc. (NASDAQ: IMMX) rose 42.2% to $2.63 in pre-market trading after declining around 14% on Wednesday. Immix Biopharma, last month, announced positive interim data from an...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 7, 2022
July 07, 2022
Upgrades
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
May 25, 2022
Gainers
Via
Benzinga
Preview: BioXcel Therapeutics's Earnings
May 06, 2022
BioXcel Therapeutics (NASDAQ:BTAI) is set to give its latest quarterly earnings report on Monday, 2022-05-09. Here's what investors need to know before the announcement. Analysts estimate that BioXcel...
Via
Benzinga
The Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Application, Cortexyme Layoffs
May 03, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours.
Via
Benzinga
Attention Biotech Investors: Mark Your Calendar For May PDUFA Dates
May 01, 2022
The month of April was a mixed one for regulatory approvals. The Food and Drug Administration delayed approvals for at least three treatment candidates. New molecular entity, or NME, approvals, a...
Via
Benzinga
How To Attend BioXcel Therapeutics Q1 2022 Earnings Conference Call
April 27, 2022
BioXcel Therapeutics (NASDAQ:BTAI) will host a conference call at 08:30 AM ET on May 9, 2022, to discuss Q1 2022 earnings results.
Via
Benzinga
The Daily Biotech Pulse: Regeneron Acquires Checkmate Pharma, Moderna's Bivalent Booster COVID-19 Vaccine Update, Priority Review For AstraZeneca's Enhertu
April 19, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours.
Via
Benzinga
The Week Ahead In Biotech (April 10-April 16): Regeneron FDA Decision, Cancer Conference Presentations And More
April 10, 2022
Biotech stocks managed to carve out modest gains for the week ending April 8, defying the broader market weakness. The defensive nature of the stocks make them appealing in times of risk aversion.
Via
Benzinga
Looking Into Bioxcel Therapeutics Inc's Recent Short Interest
April 07, 2022
Bioxcel Therapeutics Inc's (NASDAQ:BTAI) short percent of float has risen 10.66% since its last report. The company recently reported that it has 1.87 million shares sold short,...
Via
Benzinga
Benzinga's Daily Brief On Trending Tickers For April 7, 2022: SDPR S&P 500, Houghton Mifflin, Sunshine Biopharma And More
April 07, 2022
Benzinga’s “Daily Brief On Trending Tickers” highlights top-searched tickers from around the web and uses the Benzinga Pro platform to highlight recent news...
Via
Benzinga
4 Top Stock Trades for Thursday: MSFT, TWTR, BTAI, PXD
April 06, 2022
Microsoft, Twitter, BioXcel Therapeutics and Pioneer Natural Resources were our top stock trades for Thursday. Here's the trade now.
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's Intraday Session
April 06, 2022
Gainers Sunshine Biopharma (NASDAQ:SBFM) shares rose 32.4% to $7.43 during Wednesday's regular session. Sunshine Biopharma's stock is trading at a volume of 46.8...
Via
Benzinga
40 Stocks Moving In Wednesday's Mid-Day Session
April 06, 2022
Gainers Advent Technologies Holdings, Inc. (NASDAQ: ADN) shares jumped 77.7% to $3.5950. Advent Technologies and Hyundai Motor Company entered into technology assessment, sales...
Via
Benzinga
Why BioXcel Therapeutics Stock Is Surging Today
April 06, 2022
BioXcel Therapeutics Inc (NASDAQ: BTAI) shares are trading higher Wednesday after the company announced that the U.S. Food and Drug Administration approved IGALMI (...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
April 06, 2022
Gainers Healthcare Triangle (NASDAQ:HCTI) stock moved upwards by 17.5% to $1.35 during Wednesday's pre-market session. The company's market cap stands at $47.6...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.